Social Aspects (2) Efforts against cancer Cancer is one of the five priority areas. We launched Fujifilm Nishi-Azabu Endoscopic Screening Clinic on the first floor of Fujifilm Nishi-Azabu Building in 2014. For employees who require endoscope, we use our own system which incorporates our unique advanced technology. The system includes transnasal endoscope which reduces nausea caused by gag reflex that tends to occur with conventional transoral endoscope. In April 2022, we opened FUJIFILM Mediterrace Yokohama, a medical clinic for Fujifilm Group Health Insurance Association members, in FUJIFILM Business Innovation Yokohama Minatomirai Center. The clinic is equipped with the Fujifilm Group’s latest endoscope and mammography systems, as well as an AI-driven medical IT system, enabling us to offer high-quality health checkup services to our employees. Moving forward, by fiscal 2025, we strive to bring this employees’ health checkup rate to 90% at lowest for stomach cancer, large intestine cancer, breast cancer, and cervical cancer. We promote this initiative with our strong will to minimize the number of Group employees passing away from cancer by increasing the chances of early cancer detection and receiving appropriate treatment. Cancer Screening (Fujifilm Group Health Insurance Association Subsidy Program) Cancer type Procedure Target Group Interval Stomach Endoscopy (X-ray) Over 35/over 40 Annual Esophagus Fecal occult blood test Over 35/over 40 Annual Large Intestine Once during Colonoscopy Over 50 employment period Ultrasound (under 39) Breast Female Annual Mammography (over 40) Cervical Cytologic diagnosis Female Annual Prostate PSA (blood) Male over 50 Biennial Lung Chest helical CT Over 40 Annual Liver, kidney, pancreatic, biliary tract Ultrasound Over 35/over 40 Annual 117 FUJIFILM Holdings Corporation Sustainability Report 2023